VIVOCannabisLogo.jpg
ABcann Global Appoints New Independent Chair
17 oct. 2017 07h00 HE | ABcann Medicinals
NAPANEE, Ontario, Oct. 17, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) today announces that Ken Clement, founder and Executive Chair, has decided to...
VIVOCannabisLogo.jpg
ABcann Global Appoints Barry Fishman as Chief Executive Officer
07 sept. 2017 08h00 HE | ABcann Medicinals
NAPANEE, Ontario, Sept. 07, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce the appointment of Barry Fishman as Chief Executive...
VIVOCannabisLogo.jpg
ABcann Releases High Level CBD Product and Launches Initial Oils Strategy
28 août 2017 05h30 HE | ABcann Medicinals
OTTAWA, Aug. 28, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce the release of one of Canada's highest legal CBD:THC...
VIVOCannabisLogo.jpg
ABcann and Cannabis Wheaton Announce Closing of $15 Million Investment
02 août 2017 05h00 HE | ABcann Medicinals
OTTAWA, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated July 10, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (“ABcann”) and Cannabis...
VIVOCannabisLogo.jpg
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange
12 juil. 2017 08h00 HE | ABcann Medicinals
OTTAWA, July 12, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that its common shares have been approved for trading on the OTCQB...
VIVOCannabisLogo.jpg
ABcann and Cannabis Wheaton Announce Signing of Agreement for First Tranche $15 Million Investment
10 juil. 2017 01h27 HE | ABcann Medicinals; Cannabis Wheaton Income Corp.
OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) -- Further to their joint news release dated May 29, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (“ABcann”) and Cannabis Wheaton Income...
VIVOCannabisLogo.jpg
ABcann Global Extends Research Agreement with the University of Guelph
26 juin 2017 08h00 HE | ABcann Medicinals
OTTAWA, June 26, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) ("ABcann" or the "Company") is pleased to announce that it has amended and extended the research contract currently...
VIVOCannabisLogo.jpg
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility VANCOUVER, British Columbia, May 29, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX.V:ABCN) (formerly Panda Capital Inc.) (“ABcann”) and Cannabis Wheaton Income Corp. (TSX.V:CBW) ("Cannabis...
VIVOCannabisLogo.jpg
ABcann Extends Agreement With Medical Cannabis Pioneer
09 mai 2017 07h30 HE | ABcann Medicinals
OTTAWA, May 09, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (the “Company”) is pleased to announce that  Raphael Mechoulam has agreed to extend his role as an advisor to the...
VIVOCannabisLogo.jpg
ABcann Global Announces Appointment of W. Brett Wilson to Advisory Board
04 mai 2017 08h30 HE | ABcann Medicinals
NAPANEE, Ontario, May 04, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the...